2Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluororacil after curative resection of cancer of the pancreas and periampullary region: Phase Ⅲ trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg, 1999,230. 776 - 782.
3Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherpy and chemotherapy after resection of pancreatic cancer. N Engl J Med,2004,350:1200 -1210.
4Regine WF, Winter KW, Abrams RA,et al. RTOG 9704 a Phase Ⅱ study of adjuvant pre and post chemoradioation (CRT) 5-FU vs Gemcitabine (G) for resected pancreatic adenoeareinoma. J Clin Oneol, 2006,24 : NO, 18 S ( June 20 suppl). Abstract 4007.
5Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA ,2007,297 : 267 - 277.
6Neoptolemos J, Bhler M, Stocken D D, et al. A multicenter, international, open-label, randomized, controlled phase Ⅲ trial of adjuvant 5-fluorouraciL/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. J Clin Oncol ,2009,27 : 18s, ( suppl ; abstr LBA4505 ).
7Boeck S, Ankerst DP, Heinemann V. The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis. Oncology, 2007,72 (5 -6) :314 -21.
